Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

Kristof Theys*, Koen Deforche, Jurgen Vercauteren, Pieter Libin, David A.M.C. van de Vijver, Jan Albert, Birgitta Åsjö, Claudia Balotta, Marie Bruckova, Ricardo J. Camacho, Bonaventura Clotet, Suzie Coughlan, Zehava Grossman, Osamah Hamouda, Andrzei Horban, Klaus Korn, Leontios G. Kostrikis, Claudia Kücherer, Claus Nielsen, Dimitrios ParaskevisMario Poljak, Elisabeth Puchhammer-Stockl, Chiara Riva, Lidia Ruiz, Kirsi Liitsola, Jean Claude Schmit, Rob Schuurman, Anders Sönnerborg, Danica Stanekova, Maja Stanojevic, Daniel Struck, Kristel Van Laethem, Annemarie M.J. Wensing, Charles A.B. Boucher, Anne Mieke Vandamme, E. Puchhammer-Stockl, M. Sarcletti, B. Schmied, M. Geit, G. Balluch, J. Vercauteren, I. Derdelinckx, A. Sasse, M. Bogaert, H. Ceunen, A. De Roo, S. De Wit, K. Deforche, F. Echahidi, on behalf of the SPREAD-programme

*Corresponding author for this work

    Research output: Contribution to journal › Article › Research › peer-review

    24 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients'. Together they form a unique fingerprint.

    Immunology and Microbiology